Medicines in the same class as popular weight-loss therapies Ozempic and Wegovy may carry an increased risk of pancreatitis, intestinal blockage and stomach paralysis compared to an older obesity drug, Canadian researchers find.
from CBC | Health News https://ift.tt/N9v1lae
Aucun commentaire:
Enregistrer un commentaire